Hideyuki Akaza - Concepedia

Concepedia

Author

Hideyuki Akaza

University of Tsukuba

Also Known As

H. AKAZA, H. Akaza, Hideyuki Akaza

21

Publications

1.4K

Citations

14

H-Index

20

Concepts

All Affiliations

University of Tsukuba Kyushu University The University of Tokyo Sapporo Medical University Osaka International Cancer Institute

HA

About

Hideyuki Akaza is an author at University of Tsukuba specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	280
2	Public Health	1	1	64
3	Epidemiology	1	1	64
4	Global Health	1	1	64
5	International Health	1	1	64

Hideyuki Akaza

×

14

Publications

1.4K

Citations

14

H-Index

	Year	Citations
Preventive Effect of a Lactobacilluscasei Preparation on theRecurrence of Superficial BladderCancer in a Double-Blind Trial Yoshio Aso, Hideyuki Akaza, Toshihiko Kotake, European Urology	1995	375
Comparisons of Percent Equol Producers between Prostate Cancer Patients and Controls: Case-controlled Studies of Isoflavones in Japanese, Korean and American Residents Hideyuki Akaza Japanese Journal of Clinical Oncology	2004	243
Incidence of venous thromboembolism following major abdominal surgery: a multi‐center, prospective epidemiological study in Japan Masato Sakon, Yoshihiko Maehara, Hiroyuki Yoshikawa, Journal of Thrombosis and Haemostasis ThrombosisVenous DiseaseVenous ThrombosisPatient SafetyVascular Surgery	2006	143
A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety Hirotsugu Uemura, Nozomi Shinohara, Takeshi Yuasa, Japanese Journal of Clinical Oncology	2009	137
Superior Anti-tumor Efficacy of Bicalutamide 80 mg in Combination with a Luteinizing Hormone-releasing Hormone (LHRH) Agonist Versus LHRH Agonist Monotherapy as First-line Treatment for Advanced Prostate Cancer: Interim Results of a Randomized Study in Japanese Patients Hideyuki Akaza Japanese Journal of Clinical Oncology	2004	81
Phase II study ofcis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract Hideyuki Akaza, Masaki Togashi, Yasunori Nishio, Cancer Chemotherapy and Pharmacology UrologyProstatic CancerGenitourinary CancerUrinary TractMedicine	1992	73
Current Status of Endocrine Therapy for Prostate Cancer in Japan Analysis of Primary Androgen Deprivation Therapy on the Basis of Data Collected by J-CaP Shiro Hinotsu, Hideyuki Akaza, M Usami, Japanese Journal of Clinical Oncology	2007	73
Prostate Cancer Working Group Report Mikio Namiki, Hideyuki Akaza, S. E. Lee, Japanese Journal of Clinical Oncology UrologySurgical OncologyEpidemiologyPreventive MedicineGenitourinary Cancer	2010	64
Decreased expression of α-catenin is associated with poor prognosis of patients with localized renal cell carcinoma Toru Shimazui, Pierre Paul Bringuier, H. Berkel, International Journal of Cancer	1997	48
Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan Mizuki Onozawa, Shiro Hinotsu, T. Tsukamoto, Japanese Journal of Clinical Oncology	2014	48

Page 1